Lot-traced · COA on file · Sterility & mycoplasma tested
PEPTIDE DOSE: Select dose
DRAW SYRINGE TO: Select values
YOUR VIAL CONTAINS: Select values
CONCENTRATION: Select values
Tirzepatide is an innovative dual-action peptide that targets both Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. This unique mechanism has made it a significant focus of metabolic research, particularly in studies involving blood glucose regulation, weight management, and overall metabolic health.
Al imitar las hormonas incretinas naturales del organismo, la Tirzepatida ayuda a favorecer la secreción de insulina en respuesta a niveles elevados de glucosa en sangre, al tiempo que reduce el apetito y ralentiza el vaciamiento gástrico. Estas acciones combinadas contribuyen a mejorar la eficiencia metabólica y el control glucémico.
Apply once, get reviewed by our team, and access provider-only pricing across peptides, exosomes, and cellular products.
PRODUCT USAGE: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product is intended strictly for laboratory research and qualifies under appropriate regulatory frameworks for research-only use. It is not intended to diagnose, treat, cure, or prevent any disease or condition. This product should only be handled by licensed, qualified professionals. It is not intended for use by the general public. Bodily introduction of any kind into humans or animals is strictly forbidden by law.